Posted by Jack
“Unprecedented” Breakthrough in Fighting Cancer with Genetically Engineered T-Cells
Originally posted on February 20, 2016
A new cancer therapy using patients’ own modified white blood cells to target cancer cells and remain in the body to protect it from future cancer tumor growth has scientists saying the breakthrough is “unprecedented in medicine.”
The news unfolded at the Annual Meeting of the American Association for the Advancement of Science (AAAS 2016) in Washington, DC, with three international leaders in the field of cancer research: Prof. Dirk Busch of the Technical University of Munich (TUM), Prof. Chiara Bonini of the San Raffaele Scientific Institute, and Prof. Stanley Riddell of the Fred Hutchinson Cancer Research Center.
In one study presented at the meeting, 94% of study participants with Acute Lymphoblastic Leukemia (ALL) had complete elimination of their symptoms after they were treated with the modified T-Cells.
In another study, more than 50% of participants with non-Hodgkin’s lymphoma were symptom free, while 80% of them had a positive response.
For the full story, click here.